Biomedical subjects

M Muruganandham

Publications and source records attributed to M Muruganandham.

5 recordsLinked to original sources

PubMed2006

A comparative study of quantum yield and electrical energy per order (E(Eo)) for advanced oxidative decolourisation of reactive azo dyes by UV light.

This paper evaluates the quantum yield and electrical energy per order (E(Eo)) efficiency of Reactive Orange 4 (RO4) and Reactive Yellow 14 (RY14) azo dyes by three advanced oxidation processes (AOPs). Both dyes were completely decolourised by all these processes. The relative decolourisation efficiencies of these processes were in the following order: Fe(2+)/H(2)O(2)/UV>UV/TiO(2)>UV/H(2)O(2). The low efficiency of UV/H(2)O(2) process is mainly due to low UV absorption by hydrogen peroxide at the 365nm. The figure of merit E(Eo) values showed that UV/H(2)O(2) process consumes more electrical energy than the other two processes. The electrical energy consumption is in the following order: UV/H(2)O(2)>UV/TiO(2)>Fe(2+)/H(2)O(2)/UV. At low initial dye concentration higher quantum yield was observed in UV/TiO(2) process, whereas in photo-Fenton process higher quantum yield was observed at high initial dye concentration. The structure of dye molecule also influences the quantum yield and E(Eo) value.

Azo Compounds↗

PubMed2006

Solar assisted photocatalytic and photochemical degradation of Reactive Black 5.

The photocatalytic oxidative degradation of Reactive Black 5 (RB 5) has been investigated using TiO(2)-P25 as photocatalyst and sunlight as irradiation source in slurry form. The degradation was carried out at different experimental conditions to optimize the parameters such as amount of catalyst, concentration of dye and pH. A complete degradation of 3.85 x 10(-4) M dye solution under solar irradiation was observed in 3.5 h. The photochemical degradation using hydrogen peroxide results in the partial removal of the dye.

Catalysis↗

PubMed2006

TiO2-UV photocatalytic oxidation of Reactive Yellow 14: effect of operational parameters.

The photocatalytic decolourisation and degradation of an azo dye Reactive Yellow (RY14) in aqueous solution with TiO(2) as photocatalyst in slurry form has been carried out using UV-A radiation (365 nm). The effect of various parameters such as catalyst loading, radiation intensity and initial dye concentration on the dye removal was investigated to find optimum conditions. The decolourisation and degradation kinetics have been analysed. Both follow modified Langmuir-Hinshelwood kinetic (L-H) model. A study on the effect of electron acceptors on photooxidation reveals that both decolourisation and degradation increase in the presence of H(2)O(2), (NH(4))(2)S(2)O(8), KBrO(3), to certain dosage beyond which the enhancement effect is negligible. But negative effects are observed in the presence of NaCl or Na(2)CO(3).

Azo Compounds↗

PubMed1999

Diltiazem enhances tumor blood flow: MRI study in a murine tumor.

PURPOSE: Diltiazem, a calcium-channel blocker, is known to differentially influence the radiation responses of normal and murine tumor tissues. To elucidate the underlying mechanisms, the effects of diltiazem on the radiation response of Ehrlich ascites tumor (EAT) in mice have been investigated, and the hemodynamic changes induced by diltiazem in tumor and normal muscle have been studied using magnetic resonance imaging (MRI) techniques. METHODS AND MATERIALS: Ehrlich ascites tumors were grown subcutaneously in Swiss albino strain A mice. Dynamic gadodiamide and blood oxygen level dependent (BOLD) contrast enhanced 1H MR imaging studies of EAT and normal muscle were performed after administration of diltiazem in mice using a 4.7 Tesla MR scanner. Tumor radiotherapy experiments (total dose = 10 Gy, 0.4-0.5 Gy/min, single fraction) were carried out with 30 min preadministration of diltiazem (27.5 or 55 mg/kg i.p.) to EAT-bearing mice using a teletherapy machine. RESULTS: The diltiazem+ radiation treated group showed significant tumor regression (in approximately/= 65% of the animals) and enhanced animal survival. MR-gadodiamide contrast kinetics revealed a higher magnitude of signal enhancement in diltiazem treated groups as compared to the controls. The observed changes in the magnitude of kinetic parameters were the same for both tumor and normal muscle. BOLD-MR images at 30 min after diltiazem administration showed a 25% and 8% (average) intensity enhancement from their basal values in tumor and normal muscle regions, respectively. The control group showed no significant changes. CONCLUSION: The present studies demonstrate the radiosensitization potential of diltiazem in the mice EAT model. The enhanced radiation response observed with diltiazem correlates with the diltiazem-induced increase in tumor blood flow (TBF) and tumor oxygenation. The present results also demonstrate the applications of BOLD-MR measurements in investigating the alterations in tumor oxygenation status.

Animals↗

PubMed1997

Binding of monomeric and oligomeric porphyrins to human glioblastoma (U-87MG) cells and their photosensitivity.

The binding of monomeric (Hp) and oligomeric (PHE) forms of porphyrin to glioblastoma (U-87MG) cells and the photosensitization of these cells have been studied. Upon binding to U-87MG cells, Hp and PHE exhibited fluorescence bands at 615 and 636 nm, respectively. The fluorescence and absorption spectra of Hp, HpD and PHE, measured in different solvents, suggest that the 615 nm band may arise due to the binding of monomeric as well as aggregated forms of porphyrin to the hydrophilic sites in the cells whereas the 636 nm band may be due to the binding of an aggregated form of porphyrin to the hydrophobic sites. The photosensitivity of cells and photo-induced lipid peroxidation were measured as a function of light dose. Cells were found most photosensitive to PHE followed by HpD and Hp. The photosensitivity of cells correlates well with the fluorescence intensity of cell bound dye at 636 nm. These results suggest that the binding of the oligomeric component of HpD to hydrophobic sites in the cells is responsible for the enhancement in the photosensitivity.

Brain Neoplasms↗